The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
This study is currently recruiting participants.
Verified June 2012 by University of Utah
Sponsor:
University of Utah
Collaborator:
Shire Human Genetic Therapies, Inc.
Information provided by:
University of Utah
ClinicalTrials.gov Identifier:
NCT01412372
First received: June 24, 2011
Last updated: June 4, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |